Stéphan F, Réville P, de Laharpe F, Köll-Back M H
Life Sci. 1982;30(7-8):623-31. doi: 10.1016/0024-3205(82)90278-8.
Renal compensatory hypertrophy (RCH) occurs in hypothyroid rate, but it is impaired when compared to RCH found in euthyroid controls. It is due to cellular hypertrophy as the DNA content does not change and the Protein/DNA ratio increases in the compensating kidney. RCH is enhanced by thyroxine (T4) with a rise in the DNA content of the compensating kidney, but the Protein/DNA ratio does not change indicating that hypertrophy is as important as hyperplasia. Corticotrophin (ACTH) given to eu and hypothyroid rats enhances RCH with an increase in the protein content of the compensating kidney without any change in its DNA content. In the hyperthyroid rats, the enhanced RCH is not further increased by ACTH and the rise in the kidney DNA content elicited by T4 is suppressed by ACTH. The Protein/DNA ratio is increased by ACTH in hypo, eu and hyperthyroid rats. The renotrophic action of ACTH is due to hyperadrenocorticism: it is related to an increased plasma testosterone level and to a disturbed Na+, K+ and glucose metabolism.
肾代偿性肥大(RCH)发生于甲状腺功能减退的大鼠,但与甲状腺功能正常的对照组相比,其肾代偿性肥大受到损害。这是由于细胞肥大,因为在代偿性肾脏中DNA含量不变而蛋白质/DNA比值增加。甲状腺素(T4)可增强RCH,代偿性肾脏的DNA含量增加,但蛋白质/DNA比值不变,这表明肥大与增生同样重要。给甲状腺功能正常和甲状腺功能减退的大鼠注射促肾上腺皮质激素(ACTH)可增强RCH,代偿性肾脏的蛋白质含量增加,而其DNA含量无任何变化。在甲状腺功能亢进的大鼠中,ACTH不会进一步增强已增强的RCH,并且ACTH会抑制T4引起的肾脏DNA含量升高。在甲状腺功能减退、甲状腺功能正常和甲状腺功能亢进的大鼠中,ACTH均可使蛋白质/DNA比值升高。ACTH的促肾营养作用归因于肾上腺皮质功能亢进:它与血浆睾酮水平升高以及钠、钾和葡萄糖代谢紊乱有关。